Department of Medicine, Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY 10029, USA.
Liver Int. 2012 Feb;32(2):189-98. doi: 10.1111/j.1478-3231.2011.02573.x. Epub 2011 Jun 28.
Among the pathogenesis and risk factors of alcoholic liver disease (ALD) are the source of dietary fat, obesity, insulin resistance, adipokines and acetaldehyde. Translocation of Gram-negative bacteria from the gut, the subsequent effects mediated by endotoxin, and the increased production of matricellular proteins, cytokines, chemokines and growth factors, actively participate in the progression of liver injury. In addition, generation of reactive oxygen and nitrogen species and the activation of non-parenchymal cells also contribute to the pathophysiology of ALD. A key event leading to liver damage is the transition of quiescent hepatic stellate cells into activated myofibroblasts, with the consequent deposition of fibrillar collagen I resulting in significant scarring. Thus, it is becoming clearer that matricellular proteins are critical players in the pathophysiology of liver disease; however, additional mechanistic insight is needed to understand the signalling pathways involved in the up-regulation of collagen I protein. At present, systems biology approaches are helping to answer the many unresolved questions in this field and are allowing to more comprehensively identify protein networks regulating pathological collagen I deposition in hopes of determining how to prevent the onset of liver fibrosis and/or to slow disease progression. Thus, this review article provides a snapshot on current efforts for identifying pathological protein regulatory networks in the liver using systems biology tools. These approaches hold great promise for future research in liver disease.
在酒精性肝病 (ALD) 的发病机制和危险因素中,包括膳食脂肪的来源、肥胖、胰岛素抵抗、脂肪因子和乙醛。革兰氏阴性菌从肠道易位,内毒素介导的后续效应,以及细胞外基质蛋白、细胞因子、趋化因子和生长因子的产生增加,积极参与肝损伤的进展。此外,活性氧和氮物种的产生以及非实质细胞的激活也有助于 ALD 的病理生理学。导致肝损伤的关键事件是静止的肝星状细胞向激活的肌成纤维细胞转化,随之而来的纤维胶原 I 的沉积导致明显的瘢痕形成。因此,越来越清楚的是细胞外基质蛋白是肝病病理生理学的关键参与者;然而,需要更多的机制见解来理解涉及胶原 I 蛋白上调的信号通路。目前,系统生物学方法正在帮助回答该领域的许多未解决的问题,并能够更全面地识别调节病理性胶原 I 沉积的蛋白质网络,以期确定如何预防肝纤维化的发生和/或减缓疾病进展。因此,本文综述了目前使用系统生物学工具在肝脏中识别病理性蛋白质调节网络的研究进展。这些方法为肝脏疾病的未来研究提供了巨大的潜力。